http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2314283-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df300d4f6c7195f8761dd9d3cdf1169e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2010-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae63078d4c56d2b3b77b7262d417a7ca
publicationDate 2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2314283-A1
titleOfInvention Composition comprising anisic acid and an acid buffer
abstract The present invention relates to a composition, a form of dosage comprising this composition, and also the use of the composition or the form of dosage as a medicine. n It is an object of the present invention to provide a composition that prevents, reduces or cures infections, and promotes the growth of commensal microorganisms. n Another object of the present invention is to provide a composition that is suitable for use as an intimate product such as vaginal capsules.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015410635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3355893-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166968-B2
priorityDate 2009-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1325731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006229291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006053170-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129511767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129792445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129569227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129739415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127800946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129892926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127584618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1150344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129573379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128255869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127718590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12910686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127849272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427785

Total number of triples: 52.